Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.

 

Our client relationships are long term and they are underpinned by one simple commitment:

 

We will be exceptional, always.

 

6600+
Employees globally
61%
Contributed to almost 61% of FDA approved NMEs from 2017/19
50+
Years’ experience
25
Work with top 25 BioPharma companies
18
Facilities globally

Partnering to advance human health

Explore our locations

Almac Discovery

Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.

Find out more

Upcoming Events

See all events

European Peptide Symposium 2022

28 August 2022 Barcelona

Event Details

13th APS PharmSci International Conference 2022

7 September 2022 Europa Hotel, Great Victoria Street, Belfast

Event Details

Pharma ChemOutsourcing 2022

8 September 2022 Parsippany, NJ

Event Details
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies